Dear Chairman Blunt, Chairwoman DeLauro, Ranking Members Murray and Cole:

As members of One Voice Against Cancer (OVAC), a broad coalition of public interest groups representing millions of cancer patients, researchers, providers, survivors and their families, we are writing regarding funding for cancer research and prevention priorities for Fiscal Year 2020 (FY 2020).

The more than 200 diseases that we call “cancer” take a tremendous toll on our nation. It is estimated that more than 1.7 million people in the U.S. will be diagnosed with cancer this year. Additionally, more than 606,000 Americans will die from the disease in 2019, which translates to more than 1,660 people a day. Recent estimates show that cancer costs the U.S. economy more than $216 billion annually in direct treatment costs and lost productivity, a number that will increase dramatically as incidence rates climb. Additionally, it has been projected that 2.1 million people in the U.S. will be diagnosed in 2030…